Skip to Content

Ivy Emerging Markets Equity I IPOIX

Analyst rating as of
Premium

Morningstar’s Analysis

Will IPOIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An emerging-markets equity offering with some outstanding questions.

Associate Director

Summary

| |

Ivy Emerging Markets Equity is a reasonable offering, but better options exist. Most of its share classes maintain their Morningstar Analyst Ratings of Neutral, while the very expensive B share class falls to Negative.

Unlock our full analysis with Morningstar Premium